<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.jnrbm.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Journal of Negative Results in BioMedicine - Most accessed articles</title>
        <link>http://www.jnrbm.com</link>
        <description>The most accessed research articles published by Journal of Negative Results in BioMedicine</description>
        <dc:date>2010-08-20T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/5/1/17" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/9/1/7" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/9/1/6" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/9/1/2" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/9/1/1" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/8/1/11" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/9/1/5" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/9/1/3" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/7/1/11" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/6/1/2" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.jnrbm.com/content/5/1/17">
        <title>A critique of the WHO TobReg&apos;s &quot;Advisory Note&quot; report entitled: &quot;Waterpipe tobacco smoking: health effects, research needs and recommended actions by regulators&quot;</title>
        <description>Background and aimThe World Health Organisation Study Group on Tobacco Product Regulation (TobReg) has issued in 2005 an &quot;Advisory Note&quot; entitled: &quot;Waterpipe Tobacco Smoking: Health Effects, Research Needs and Recommended Actions by Regulators&quot;. &quot;Waterpipe&quot; smoking is now considered a global public health threat and the corresponding artefact is actually known in the world under three main terms: hookah, narghile and shisha. This important report, the first ever prepared by WHO on the subject, poses two major problems. On one hand, its bibliographical references dismiss world chief relevant studies. On the other, it contains a certain number of errors of many orders: biomedical, sociological, anthropological and historical. The purpose of the present study is to highlight, one by one, where these weaknesses and errors lie and show how this official report can be considerably improved.
Results:
We realise that widely advertised early anthropological studies were not taken into consideration whereas they shed a substantial light on this peculiar form of smoking and help understanding its high complexity. As for concrete errors to be found in this report, they deal with the chemistry of smoke, health-related effects, smoking patterns, description and history of the artefact and its use, gender and underage use aspects, prevention and research needs in this field.
Conclusion:
The scientific credibility of an international expert report may be at stake if its recommendations do not rely on sound objective research findings and a comprehensive review of the existing literature. The critical comments in this study will certainly help improve the present WHO report.</description>
        <link>http://www.jnrbm.com/content/5/1/17</link>
                <dc:creator>Kamal Chaouachi</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2006, 5:17</dc:source>
        <dc:date>2006-11-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-5-17</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>17</prism:startingPage>
        <prism:publicationDate>2006-11-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/9/1/7">
        <title>Generation of a panel of antibodies against proteins encoded on human chromosome 21</title>
        <description>Background:
Down syndrome (DS) is caused by trisomy of all or part of chromosome 21.  To further understanding of DS we are working with a mouse model, the Tc1 mouse, which carries most of human chromosome 21 in addition to the normal mouse chromosome complement. This mouse is a model for human DS and recapitulates many of the features of the human syndrome such as specific heart defects, and cerebellar neuronal loss.  The Tc1 mouse is mosaic for the human chromosome such that not all cells in the model carry it. Thus to help our investigations we aimed to develop a method to identify cells that carry human chromosome 21 in the Tc1 mouse.  To this end, we have generated a panel of antibodies raised against proteins encoded by genes on human chromosome 21 that are known to be expressed in the adult brain of Tc1 mice
Results:
We attempted to generate human specific antibodies against proteins encoded by human chromosome 21.  We selected proteins that are expressed in the adult brain of Tc1 mice and contain regions of moderate/low homology with the mouse ortholog.  We produced antibodies to seven human chromosome 21 encoded proteins.  Of these, we successfully generated three antibodies that preferentially recognise human compared with mouse SOD1 and RRP1 proteins on western blots.   However, these antibodies did not specifically label cells which carry a freely segregating copy of Hsa21 in the brains of our Tc1 mouse model of DS.
Conclusions:
Although we have successfully isolated new antibodies to SOD1 and RRP1 for use on western blots, in our hands these antibodies have not been successfully used for immunohistochemistry studies.  These antibodies are freely available to other researchers.  Our data high-light the technical difficulty of producing species-specific antibodies for both western blotting and immunohistochemistry.</description>
        <link>http://www.jnrbm.com/content/9/1/7</link>
                <dc:creator>Frances Wiseman</dc:creator>
                <dc:creator>Olivia Sheppard</dc:creator>
                <dc:creator>Jacqueline Linehan</dc:creator>
                <dc:creator>Sebastian Brandner</dc:creator>
                <dc:creator>Victor Tybulewicz</dc:creator>
                <dc:creator>Elizabeth Fisher</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2010, 9:7</dc:source>
        <dc:date>2010-08-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-9-7</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2010-08-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/9/1/6">
        <title>A comparison of meningococcal carriage by pregnancy status</title>
        <description>Neisseria meningitidis is the second leading cause of invasive meningitis. A prerequisite for infection is colonization of the nasopharynx, and asymptomatic carrier rates are widely reported in the range of 10-15%. Recent reports have indicated an increased likelihood that a pediatric admission for Neisseria meningitidis will have a mother who is pregnant in the home. We hypothesized that this association may relate to immunologic changes in pregnancy leading to higher carrier rates.We compared the carrier status by performing nasopharyngeal swabs for Neisseria meningitidis in 100 pregnant and 99 non-pregnant women.Average age of the participants was 28.9 +/- 6.7 years. The average gestational age at specimen collection was 27.5 +/- 9.4 weeks. Non pregnant women were significantly more likely to use tobacco (38% vs 24%, p &lt; 0.0001). In the entire 199 patients, only one pregnant patient tested positive for Neisseria meningitidis (0.5%; 95% CI: 0.01%-2.8%).The meningococcal carrier rate in our population is well below what is widely reported in the literature. Assuming a 1% carrier rate in the pregnant group and a 0.5% carrier rate in the non pregnant group, 4,763 patients would be required to detect a difference of this magnitude, given 80% power and an alpha of 0.05.</description>
        <link>http://www.jnrbm.com/content/9/1/6</link>
                <dc:creator>Eric Knudtson</dc:creator>
                <dc:creator>Mike Lytle</dc:creator>
                <dc:creator>Beverly Vavricka</dc:creator>
                <dc:creator>Valerie Skaggs</dc:creator>
                <dc:creator>Jennfier Peck</dc:creator>
                <dc:creator>Andrew Elimian</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2010, 9:6</dc:source>
        <dc:date>2010-08-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-9-6</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2010-08-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/9/1/2">
        <title>Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression </title>
        <description>The transcription factor Oct4 is well defined as a key regulator of embryonic stem (ES) cell pluripotency. In recent years, the role of Oct4 has purportedly extended to the self renewal and maintenance of multipotency in adult stem cell (ASC) populations. This profile has arisen mainly from reports utilising reverse transcription-polymerase chain reaction (RT-PCR) based methodologies and has since come under scrutiny following the discovery that many developmental genes have multiple pseudogenes associated with them. Six known pseudogenes exist for Oct4, all of which exhibit very high sequence homology (three &gt;97%), and for this reason the generation of artefacts may have contributed to false identification of Oct4 in somatic cell populations. While ASC lack a molecular blueprint of transcription factors proposed to be involved with &apos;stemness&apos; as described for ES cells, it is not unreasonable to assume that similar gene patterns may exist. The focus of this work was to corroborate reports that Oct4 is involved in the regulation of ASC self-renewal and differentiation, using a combination of methodologies to rule out pseudogene interference. Haematopoietic stem cells (HSC) derived from human umbilical cord blood (UCB) and various differentiated cell lines underwent RT-PCR, product sequencing and transfection studies using an Oct4 promoter-driven reporter. In summary, only the positive control expressed Oct4, with all other cell types expressing a variety of Oct4 pseudogenes. Somatic cells were incapable of utilising an exogenous Oct4 promoter construct, leading to the conclusion that Oct4 does not appear involved in the multipotency of human HSC from UCB.</description>
        <link>http://www.jnrbm.com/content/9/1/2</link>
                <dc:creator>Zoe Redshaw</dc:creator>
                <dc:creator>Alastair Strain</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2010, 9:2</dc:source>
        <dc:date>2010-03-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-9-2</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2010-03-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/9/1/1">
        <title>Does computer use pose a hazard for future long-term sickness absence?</title>
        <description>The aim of the study was to investigate if weekly duration of computer use predicted sickness absence for more than two weeks at a later time.A cohort of 2146 frequent computer users filled in a questionnaire at baseline and was followed for one year with continuously recording of the duration of computer use and furthermore followed for 300 weeks in a central register of sickness absence for more than 2 weeks.147 participants of the 2,146 (6.9%) became first time sick listed in the follow-up period. Overall, mean weekly computer use did not turn out to be a risk factor for later sickness absence. The hazard ratio for sickness absence with weekly increase of one hour in computer use was 0.99 (95% CI: 0.99 to 1.00). Low satisfaction with work place arrangements and female gender both doubled the risk of sickness absence.We have earlier found that computer use did not predict persistent pain in the neck and upper limb, and it seems that computer use neither predicts future long-term sickness absence of all causes.</description>
        <link>http://www.jnrbm.com/content/9/1/1</link>
                <dc:creator>Johan Andersen</dc:creator>
                <dc:creator>Sigurd Mikkelsen</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2010, 9:1</dc:source>
        <dc:date>2010-03-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-9-1</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2010-03-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/8/1/11">
        <title>Human spongiosa mesenchymal stem cells fail to generate cardiomyocytes in vitro</title>
        <description>Background:
Human mesenchymal stem cells (hMSCs) are broadly discussed as a promising cell population amongst others for regenerative therapy of ischemic heart disease and its consequences. Although cardiac-specific differentiation of hMSCs was reported in several in vitro studies, these results were sometimes controversial and not reproducible.
Results:
In our study we have analyzed different published protocols of cardiac differentiation of hMSCs and their modifications, including the use of differentiation cocktails, different biomaterial scaffolds, co-culture techniques, and two- and three-dimensional cultures. We also studied whether 5&apos;-azacytidin and trichostatin A treatments in combination with the techniques mentioned above can increase the cardiomyogenic potential of hMSCs. We found that hMSCs failed to generate functionally active cardiomyocytes in vitro, although part of the cells demonstrated increased levels of cardiac-specific gene expression when treated with differentiation factors, chemical substances, or co-cultured with native cardiomyocytes.
Conclusion:
The failure of hMSCs to form cardiomyocytes makes doubtful the possibility of their use for mechanical reparation of the heart muscle.</description>
        <link>http://www.jnrbm.com/content/8/1/11</link>
                <dc:creator>Svetlana Mastitskaya</dc:creator>
                <dc:creator>Bernd Denecke</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2009, 8:11</dc:source>
        <dc:date>2009-11-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-8-11</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2009-11-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/9/1/5">
        <title>The Drosophila Anion Exchanger (DAE) lacks a detectable interaction with the spectrin cytoskeleton</title>
        <description>Background:
Current models suggest that the spectrin cytoskeleton stabilizes interacting ion transport proteins at the plasma membrane. The human erythrocyte anion exchanger (AE1) was the first membrane transport protein found to be associated with the spectrin cytoskeleton. Here we evaluated a conserved anion exchanger from Drosophila (DAE) as a marker for studies of the downstream effects of spectrin cytoskeleton mutations.
Results:
Sequence comparisons established that DAE belongs to the SLC4A1-3 subfamily of anion exchangers that includes human AE1. Striking sequence conservation was observed in the C-terminal membrane transport domain and parts of the N-terminal cytoplasmic domain, but not in the proposed ankyrin-binding site. Using an antibody raised against DAE and a recombinant transgene expressed in Drosophila S2 cells DAE was shown to be a 136 kd plasma membrane protein. A major site of expression was found in the stomach acid-secreting region of the larval midgut. DAE codistributed with an infolded subcompartment of the basal plasma membrane of interstitial cells. However, spectrin did not codistribute with DAE at this site or in anterior midgut cells that abundantly expressed both spectrin and DAE. Ubiquitous knockdown of DAE with dsRNA eliminated antibody staining and was lethal, indicating that DAE is an essential gene product in Drosophila.
Conclusions:
Based on the lack of colocalization and the lack of sequence conservation at the ankyrin-binding site, it appears that the well-characterized interaction between AE1 and the spectrin cytoskeleton in erythrocytes is not conserved in Drosophila. The results establish a pattern in which most of the known interactions between the spectrin cytoskeleton and the plasma membrane in mammals do not appear to be conserved in Drosophila.</description>
        <link>http://www.jnrbm.com/content/9/1/5</link>
                <dc:creator>Ronald Dubreuil</dc:creator>
                <dc:creator>Amlan Das</dc:creator>
                <dc:creator>Christine Base</dc:creator>
                <dc:creator>G Mazock</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2010, 9:5</dc:source>
        <dc:date>2010-06-23T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-9-5</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2010-06-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/9/1/3">
        <title>Effect of venlafaxine on bone loss associated with ligature-induced periodontitis in Wistar rats</title>
        <description>Background:
The present study investigated the effects of venlafaxine, an antidepressant drug with immunoregulatory properties on the inflammatory response and bone loss associated with experimental periodontal disease (EPD).Materials and MethodsWistar rats were subjected to a ligature placement around the second upper left molar. The treated groups received orally venlafaxine (10 or 50 mg/kg) one hour before the experimental periodontal disease induction and daily for 10 days. Vehicle-treated experimental periodontal disease and a sham-operated (SO) controls were included. Bone loss was analyzed morphometrically and histopathological analysis was based on cell influx, alveolar bone, and cementum integrity. Lipid peroxidation quantification and immunohistochemistry to TNF-&#945; and iNOS were performed.
Results:
Experimental periodontal disease rats showed an intense bone loss compared to SO ones (SO = 1.61 &#177; 1.36; EPD = 4.47 &#177; 1.98 mm, p &lt; 0.001) and evidenced increased cellular infiltration and immunoreactivity for TNF-&#945; and iNOS. Venlafaxine treatment while at low dose (10 mg/kg) afforded no significant protection against bone loss (3.25 &#177; 1.26 mm), a high dose (50 mg/kg) caused significantly enhanced bone loss (6.81 &#177; 3.31 mm, p &lt; 0.05). Venlafaxine effectively decreased the lipid peroxidation but showed no significant change in TNF-&#945; or iNOS immunoreactivity.
Conclusion:
The increased bone loss associated with high dose venlafaxine may possibly be a result of synaptic inhibition of serotonin uptake.</description>
        <link>http://www.jnrbm.com/content/9/1/3</link>
                <dc:creator>Rosimary Carvalho</dc:creator>
                <dc:creator>Carolina de Souza</dc:creator>
                <dc:creator>Julliana Neves</dc:creator>
                <dc:creator>Sergio Holanda-Pinto</dc:creator>
                <dc:creator>Livia Pinto</dc:creator>
                <dc:creator>Gerly Brito</dc:creator>
                <dc:creator>Geanne de Andrade</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2010, 9:3</dc:source>
        <dc:date>2010-06-14T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-9-3</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2010-06-14T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/7/1/11">
        <title>Prospective randomized trial of iliohypogastric-ilioinguinal nerve block on post-operative morphine use after inpatient surgery of the female reproductive tract</title>
        <description>ObjectiveTo determine the impact of pre-operative and intra-operative ilioinguinal and iliohypogastric nerve block on post-operative analgesic utilization and length of stay (LOS).
Methods:
We conducted a prospective randomized double-blind placebo controlled trial to assess effectiveness of ilioinguinal-iliohypogastric nerve block (IINB) on post-operative morphine consumption in female study patients (n = 60). Patients undergoing laparotomy via Pfannenstiel incision received injection of either 0.5% bupivacaine + 5 mcg/ml epinephrine for IINB (Group I, n = 28) or saline of equivalent volume given to the same site (Group II, n = 32). All injections were placed before the skin incision and after closure of rectus fascia via direct infiltration. Measured outcomes were post-operative morphine consumption (and associated side-effects), visual analogue pain scores, and hospital length of stay (LOS).
Results:
No difference in morphine use was observed between the two groups (47.3 mg in Group I vs. 45.9 mg in Group II; p = 0.85). There was a trend toward lower pain scores after surgery in Group I, but this was not statistically significant. The mean time to initiate oral narcotics was also similar, 23.3 h in Group I and 22.8 h in Group II (p = 0.7). LOS was somewhat shorter in Group I compared to Group II, but this difference was not statistically significant (p = 0.8). Side-effects occurred with similar frequency in both study groups.
Conclusion:
In this population of patients undergoing inpatient surgery of the female reproductive tract, utilization of post-operative narcotics was not significantly influenced by IINB. Pain scores and LOS were also apparently unaffected by IINB, indicating a need for additional properly controlled prospective studies to identify alternative methods to optimize post-surgical pain management and reduce LOS.</description>
        <link>http://www.jnrbm.com/content/7/1/11</link>
                <dc:creator>Salim Wehbe</dc:creator>
                <dc:creator>Labib Ghulmiyyah</dc:creator>
                <dc:creator>El-Khawand Dominique</dc:creator>
                <dc:creator>Sarah Hosford</dc:creator>
                <dc:creator>Carole Ehleben</dc:creator>
                <dc:creator>Steven Saltzman</dc:creator>
                <dc:creator>Eric Scott Sills</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2008, 7:11</dc:source>
        <dc:date>2008-11-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-7-11</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2008-11-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/6/1/2">
        <title>Fall risk in an active elderly population - can it be assessed?</title>
        <description>Background:
Falls amongst elderly people are often associated with fractures. Training of balance and physical performance can reduce fall risk; however, it remains a challenge to identify individuals at increased risk of falling to whom this training should be offered. It is believed that fall risk can be assessed by testing balance performance. In this study a test battery of physiological parameters related to balance and falls was designed to address fall risk in a community dwelling elderly population.
Results:
Ninety-four elderly males and females between 70 and 80 years of age were included in a one year follow-up study. A fall incidence of 15% was reported. The test battery scores were not different between the fallers and non-fallers. Test scores were, however, related to self-reported health. In spite of inclusion of dynamic tests, the test battery had low fall prediction rates, with a sensitivity and specificity of 50% and 43% respectively.
Conclusion:
Individuals with poor balance were identified but falls were not predicted by this test battery. Physiological balance characteristics can apparently not be used in isolation as adequate indicators of fall risk in this population of community dwelling elderly. Falling is a complex phenomenon of multifactorial origin. The crucial factor in relation to fall risk is the redundancy of balance capacity against the balance demands of the individuals levels of fall-risky lifestyle and behavior. This calls for an approach to fall risk assessment in which the physiological performance is evaluated in relation to the activity profile of the individual.</description>
        <link>http://www.jnrbm.com/content/6/1/2</link>
                <dc:creator>Uffe Laessoe</dc:creator>
                <dc:creator>Hans Hoeck</dc:creator>
                <dc:creator>Ole Simonsen</dc:creator>
                <dc:creator>Thomas Sinkjaer</dc:creator>
                <dc:creator>Michael Voigt</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2007, 6:2</dc:source>
        <dc:date>2007-01-26T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-6-2</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2007-01-26T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
